Drug Resistant Partial Onset Seizure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Resistant Partial Onset Seizure trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Resistant Partial Onset Seizure trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
The purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizures.